IDFC First Bank approves ₹3,200 crore share issue in 2024

The board decision and why it matters

IDFC First Bank disclosed that its board approved a proposal to raise ₹3,200 crore through a preferential allotment of equity shares. The issue is priced at ₹80.63 per equity share, as per the bank’s exchange filing. The proposed allotment is aimed at raising fresh equity capital for the bank. The move matters because it increases the bank’s equity base and, as stated, supports business growth. The preferential route also brings in identified institutional investors rather than relying on open-market fundraising. The bank said the proposal is subject to shareholder approval. It also approved a postal ballot process to seek shareholder consent.

What the preferential issue includes

At its board meeting on May 30, 2024, the bank approved issuing 39,68,74,600 equity shares (face value ₹10 each, fully paid-up) on a preferential basis. The total fundraise size mentioned is ₹3,200 crore (rounded off). The issue price of ₹80.63 per share is reported as a premium of 4.51% to the previous close of ₹77.15 (the last trading day before the board meeting). The bank described the investors as marquee institutional buyers. As per the disclosure, 47% of the proposed issue is to be subscribed by LIC of India. The bank also noted that the pricing aligns with the SEBI floor price for a preferential issue.

Who will receive the shares

The proposed allottees named include Life Insurance Corporation of India (LIC), HDFC Life, Aditya Birla Sun Life Insurance, Bajaj Allianz, ICICI Lombard, and SBI General Insurance. The bank’s filings position these investors as Qualified Institutional Buyers participating via preferential allotment. The allotment structure is important because it concentrates issuance to a set of large institutions rather than a broad set of investors. The disclosure does not provide the exact share split for each investor in the excerpt, except the 47% figure referenced for LIC. The issuance is still contingent on shareholder approval through the postal ballot route approved by the board.

Equity capital impact after allotment

The bank disclosed that, following the allotment, its issued and paid-up equity share capital would increase. It is stated to rise from 707,727,684 equity shares of ₹10 each to 747,415,144 equity shares of ₹10 each, fully paid-up. This change reflects the effect of the new equity shares being issued. The bank highlighted the procedural requirement of shareholder approval for the transaction. Alongside this, it approved conducting a postal ballot to seek consent for the preferential issuance and allotment to the proposed allottees.

Capital position referenced in the filing

In the exchange filing reproduced in the provided text, the bank linked the proposed capital raise to capital adequacy. With the proposed ₹3,200 crore capital raise, the bank said its overall capital adequacy would increase to 17.49%. This calculation was described as being based on risk-weighted assets as of March 2024. The disclosure frames the capital raise as strengthening the bank’s ability to participate in future growth. The statement is presented as an outcome of the proposed fundraise, not as a broader forecast.

Separately, a 2025 CCPS fundraise and subsequent conversion

In a separate set of disclosures included in the provided material, IDFC First Bank’s board on April 17, 2025 approved an aggregate fundraise of up to approximately ₹7,500 crore from two investors: Currant Sea Investments B.V. and Platinum Invictus B 2025 RSC Limited. The board approved issuing up to 124,98,80,388 compulsorily convertible cumulative preference shares (CCPS), each with a face value of ₹10. The CCPS were described as convertible into an equal number of equity shares of the bank, each with a face value of ₹10. The CCPS issue price referenced in the excerpt is ₹60 per CCPS, by way of preferential allotment on a private placement basis. The bank also noted that the April 17, 2025 board meeting commenced at 08:00 a.m. and concluded at 08:50 a.m.

Allotments under the 2025 CCPS plan

Based on requisite approvals including from shareholders and the Reserve Bank of India, the bank’s authorised committee approved specific allotments. On August 01, 2025, it approved allotment of 81,26,94,722 CCPS to Currant Sea, aggregating to approximately ₹4,876.17 crore. On August 19, 2025, it approved allotment of 43,71,85,666 CCPS to Platinum Invictus, aggregating to approximately ₹2,623.11 crore. These figures, taken together, align with the broader fundraise referenced for two separate investors. The disclosures describe these as preferential allotments on a private placement basis.

Conversion into equity shares for Currant Sea

The bank further disclosed a conversion-related allotment. Upon fulfilment of conditions precedent to conversion, the board at its meeting held on October 08, 2025 approved allotment of 81,26,94,722 equity shares. The equity shares were of face value ₹10 each and were allotted to Currant Sea. This was stated to be pursuant to conversion of an equivalent number of CCPS held by Currant Sea. The excerpt does not describe a similar conversion event for Platinum Invictus, beyond the CCPS allotment approval mentioned earlier.

Key facts table

Timeline of disclosed actions

Market impact and what to track next

From the disclosures, the immediate procedural next step for the ₹3,200 crore equity preferential issue is shareholder approval, for which the bank approved a postal ballot process. The pricing detail, including the 4.51% premium to the prior close of ₹77.15, sets the terms for the proposed allotment. Separately, the 2025 CCPS transactions show a sequence where shareholder and RBI approvals were referenced before allotments were approved by an authorised committee. The October 2025 equity allotment to Currant Sea indicates that conversion milestones can translate into equity issuance. Investors will typically track the outcome of the postal ballot for the 2024 preferential issue, and subsequent corporate filings that confirm allotment completion, updated shareholding, and any further regulatory approvals where applicable.